• 1
    Stepan J, Pospichal J, Presl J, Pocovsky V. Bone loss and biochemical indices of bone remodelling in surgically induced post-menopausal women. Bone 1987; 8: 279284.
  • 2
    Elders JM, Netelembos JC, Lips P, Van G Inkel FC, Van Der Stelt PF. Accelerated vertebral bone loss in relation to the menopause: A cross-sectional study on lumbar bone density in 286 women of 46–55 years of age. Bone Min 1988; 5: 1119.
  • 3
    Yamazaki I, Yamaguchi H. Characteristics of an ovariectomized osteopenic rat model. J Bone Min Res 1989; 4: 1322.
  • 4
    Kalu DN, Liu CC, Hardin RR, Hollis BW. The aged rat model of ovarian hormone deficiency bone loss. Endocrinology 1989; 124: 716.
  • 5
    Goulding A, Gold E. A new way to induce oestrogen-deficiency osteopaenia in the rat: comparison of the effects of surgical ovariectomy and administration of the LHRH agonist buserelin on bone resorption and composition. J Endocrinol 1989; 121: 293298.
  • 6
    Yokose S, Ishizuya T, Ikeda T et al. An estrogen deficiency caused by ovariectomy increases plasma levels of systemic factors that stimulate proliferation and differentiation of osteoblasts in rats. Endocrinology 1996; 137: 469478.
  • 7
    Gaumet N, Seibel MJ, Braillon P et al. Influence of ovariectomy on bone metabolism in very old rats. Calcif Tissue Int 1996; 58: 256262.
  • 8
    Gaumet N, Seibel MJ, Coxam V, Davicco MJ, Lebecque P, Barlet JP. Influence of ovariectomy and estradiol treatment on calcium homeostasis during aging in rats. Arch Physiol Biochem 1997; 105: 435444.
  • 9
    Nakade O, Koyama H, Ariji H, Yajima A, Kaku T. Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro. J Pineal Res 1999; 27: 106110.
  • 10
    Roth JA, Kim BG, Lin WL, Cho MI. Melatonin promotes osteoblast differentiation and bone formation. J Biol Chem 1999; 274: 22,04122,047.
  • 11
    Ostrowska Z, Kos-Kudla B, Swietochowska E, Marek B, Kajdaniuk D, Gorski J. Assessment of the relationship between dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis. Neuroendocrinol Lett 2001; 22: 129136.
  • 12
    Ladizesky MG, Cutrera RA, Boggio V et al. Effect of melatonin on bone metabolism in ovariectomized rats. Life Sci 2001; 70: 557565.
  • 13
    Cagnacci A, Zanni AL, Veneri MG, Menozzi R, Volpe A, Rio GD. Influence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during ooestradiol replacement. Clin Endocrinol (Oxf) 2000; 53: 367372.
  • 14
    Hattori Y, Kaku T, Koyama H, Nakade O. Melatonin could prevent cancellous bone loss in ovariectomized rats. J Bone Min Res2001; 16 (Suppl. 1):S297 (Abstract)
  • 15
    Lau HM, Koyama H, Nakade O, Takada Y, Kuku T. Melatonin increases bone mass by suppressing bone resorption through down-regulation of the RANKI-mediated osteoclatogenesis in mice. J Bone Min Res 2001; 16 (Suppl. 1):S211 (Abstract)
  • 16
    Rasmussen DD, Boldt BM, Wilkinson CW, Yellon SM, Matsumoto AM. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology 1999; 140: 10091012.
  • 17
    Skinner DC, Malpaux B. High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 1999; 140: 43994405.
  • 18
    Gamst O, Try K. Determination of serum-phosphate without deproteinization by ultraviolet spectrophotometry of the phosphomolybdic acid complex. Scand J Clin Lab Invest 1980; 40: 483486.
  • 19
    Trudeau DL, Freier EF. Determination of calcium in urine and serum by atomic absorption spectrophotometry (AAS). Clin Chem 1967; 13: 101
  • 20
    Puche RC, Caferra DA, Rosillo I. Bone isoenzime of serum alkaline phosphatase measured with wheat-germ agglutinin. Clin Chem 1988; 34: 13721374.
  • 21
    Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ. Direct enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Min Res 1994; 9: 16431649.
  • 22
    Ladizesky M, Zeni S, Mautalen C. Precise measurement of bone mineral density in rats using dual-energy X-ray absorptiometry. Acta Physiol Pharmacol Ther Latinoamer 1994; 44: 3035.
  • 23
    Zeni S, Gómez-Acotto C, Mautalen C. The effect of alpadronate in ovariectomized thyroxine-treated rats. Bone 1997; 21: 329333.
  • 24
    Manolaga SC. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Rev 2000; 21: 115137.
  • 25
    Vanecek J, Kosar E, Vorlicek J. Daily changes in melatonin binding sites and the effect of castration. Mol Cell Endocrinol 1990; 73: 165170.
  • 26
    Seltzer A, Viswanathan M, Saavedra JM. Melatonin binding sites in brain and caudal arteries of the female rat during the estrous cycle and after oestrogen administration. Endocrinology 1992; 130: 18961902.
  • 27
    Cagnacci A, Arangino S, Malmusi S, Longo M, Volpe A. Melatonin in aged women. Possible modulation by oestrogens. Aging (Milano) 1997; 9: 6263.
  • 28
    Wronski TJ, Cintron M, Doherty AL, Dann LM. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 1988; 123: 681686.
  • 29
    Fraser JH, Helfrich MH, Wallace HM, Ralston SH. Hydrogen peroxide, but not superoxide, stimulates bone resorption in mouse calvariae. Bone 1996; 19: 223226.
  • 30
    Berger CE, Horrocks BR, Datta HK. Direct non-genomic effect of steroid hormones on superoxide anion generation in the bone resorbing osteoclasts. Mol Cell Endocrinol 1999; 149: 5359.
  • 31
    Melhus H, Michaelsson K, Holmberg L, Wolk A, Ljunghall S. Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 1999; 14: 129135.
  • 32
    Collin-Osdoby P, Li L, Rothe L et al. Inhibition of avian osteoclast bone resorption by monoclonal antibody 121F: a mechanism involving the osteoclast free radical system. J Bone Miner Res 1998; 13: 6778.
  • 33
    Reiter RJ, Acuna-Castroviejo D, Tan DX, Burkhardt S. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann N Y Acad Sci 2001; 939: 200215.
  • 34
    Rasmussen DD, Mitton DR, Larsen SA, Yellon SM. Aging-dependent changes in the effect of daily melatonin supplementation on rat metabolic and behavioral responses. J Pineal Res 2001; 31: 8994.
  • 35
    Wolden-Hanson T, Mitton DR, McCants RL et al. Daily melatonin administration to middle-aged male rats suppresses body weight, intra-abdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 2000; 141: 487497.
  • 36
    Okatani Y, Morioka N, Wakatsuki A. Changes in nocturnal melatonin secretion in perimenopausal women: correlation with endogenous oestrogen concentrations. J Pineal Res 2000; 28: 111118.